Noveome Biotherapeutics, Inc.

New Filing
CIK: 0001478304·Biotechnology·DELAWARE·Filed: Aug 27, 2026
Total Offering

$15,000,000

Amount Sold

$6,750,503

Investors

6

First Sale

Aug 12, 2026

Offering Details

Type
Debt, Other: Convertible promissory notes
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Patrick Welch
Robert Langer
Ronald Poropatich
Eric Keller
Houman Hemmati
Craig Nemiroff
Michael Kaufman
Karin Potoka
Larry Brown

Company

Noveome Biotherapeutics, Inc.

620 ALPHA DRIVE

PITTSBURGH, PA, 15238

412-799-6157

SEC Filing

0001478304-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Noveome Biotherapeutics, Inc. Form D Filing — $15,000,000 | FilingFlow